Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label venous thromboembolism. Show all posts
Showing posts with label venous thromboembolism. Show all posts
Thursday, May 10, 2012

Correspondence/Author's Response: Paraneoplastic Thrombocytosis in Ovarian Cancer — NEJM

›
Paraneoplastic Thrombocytosis in Ovarian Cancer — NEJM Correspondence Paraneoplastic Thrombocytosis in Ovarian Cancer N Engl J Med 2...
Saturday, March 03, 2012

abstract - EvidenceUpdates: Cochrane Review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy (including professional commentaries)

›
Abstract BACKGROUND :  Venous thromboembolism (VTE) often complicates the clinical course of cancer disease. The risk is ...
Thursday, January 26, 2012

summary: Risk of Venous and Arterial Thromboembolic Events Associated With Anti-EGFR Agents: A Meta-Analysis of Randomized Clinical Trials - OncologySTAT

›
  SUMMARY OncologySTAT Editorial Team "Venous and arterial thromboembolism events (VTEs and ATEs) are common in patients wit...
Sunday, January 15, 2012

abstract: Prevention and treatment of venous thromboembolism (blood clots) in patients with cancer

›
Thursday, June 30, 2011

abstract: Cochrane Review - Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

›
BACKGROUND: Compared to patients without cancer, patients with cancer who receive anticoagulant treatment for venous thromboembolism a...
Tuesday, January 18, 2011

abstract: Oral Contraceptives and the Risk of Venous Thromboembolism: An Update

›
Tuesday, September 14, 2010

Access : Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study (abstract)

›
Conclusions: Risk of VTE is higher among cancer patients than in the general population. Predictors of VTE include recency of cancer diagn...
Monday, September 13, 2010

Summary- Clinical burden of venous thromboembolism

›
Conclusions: Even among high-risk groups it is not possible to identify individuals who will go on to develop VTE, and, therefore, thrombo...